Alfred Morgenstern

Sequential Cytarabine and α-Particle Immunotherapy with Bismuth-213–Lintuzumab (HuM195) for Acute Myeloid Leukemia

Todd Rosenblat, Michael R. McDevitt, Deborah Mulford et al. · Clinical Cancer Research · 2010 · 264 citations · Full text

Medicine, Hematology, Oncology +17

Production of Ac-225 from Th-229 for Targeted α Therapy

Christos Apostolidis, R. Molinet, Gert Rasmussen et al. · Analytical Chemistry · 2005 · 216 citations

Medicine, Nuclear Medicine, Oncology +16

Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial

Dominik Cordier, Flavio Forrer, Frank Bruchertseifer et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2010 · 198 citations · Full text

Medicine, Nuclear Medicine, Oncology +14

Targeted alpha therapy of mCRPC: Dosimetry estimate of 213Bismuth-PSMA-617

Clemens Kratochwil, Karl Schmidt, Ali Afshar‐Oromieh et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 142 citations · Full text

Medicine, Oncology, Radiation Oncology +12

Physiologically aged red blood cells undergo erythrophagocytosis in vivo but not in vitro

Yuval Gottlieb, On Topaz, L. A. Cohen et al. · Haematologica · 2012 · 114 citations · Full text

Life Sciences, Cell Biology, Physiology +17